Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
Business Wire•13/10/2026•07:30 ET
0
Key Highlights
- ➤Smiths Falls earns EU GMP certification for manufacturing and packaging activities
- ➤Facility becomes Canada’s only site combining softgel manufacturing and packaging capabilities
- ➤Certification expands patient-ready medical cannabis supply to European markets
- ➤Canopy Growth targets accelerated commercial execution across Germany, Poland and UK
Expert Statements
Luc Mongeau, Chief Executive Officer, Canopy Growth
“We have been deliberate about putting the capabilities in place to win in Europe, from high-quality cultivation and a broader portfolio to experienced commercial leadership”
Luc Mongeau, Chief Executive Officer, Canopy Growth
“This EU GMP certification adds a capability that sets us apart and accelerates our strategy to capture more value across our supply chain.”
Luc Mongeau, Chief Executive Officer, Canopy Growth
“It is a critical step in expanding our presence across European medical cannabis markets, strengthening our ability to serve patients, and driving profitable growth.”
Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
Certification strengthens Canopy Growth’s European growth strategy and expands its integrated EU GMP supply chain
Get started
Create a free account to read the full story.